Josh Lee

Josh Lee is a project manager with years of experience in China pharmaceutical pricing and access strategies.


Maximizing China Access for Innovative Therapies

To maximize the potential of innovative therapies in the Chinese market, it’s important to have a holistic view of the full range of options and levers, prioritize and sequence the ones with the highest impacts, and develop an integrated strategy tailored to address the country’s unmet needs.